Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors

CIK cells therapy has been evaluated as an adoptive cell immunotherapy for cancer patients, but there still have not been any standardized systems for evaluating the antitumor efficacy yet. The WHO and RECIST criteria have already been established for a few years but not sufficient to fully characte...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiao-Dong, Ji, Mei, Zheng, Xiao, Ning, Zhong-Hua, Wu, Jun, Lu, Binfeng, Wu, Chang-Ping, Jiang, Jing-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256683/
https://www.ncbi.nlm.nih.gov/pubmed/25113800
http://dx.doi.org/10.1186/s12967-014-0215-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256683/
https://www.ncbi.nlm.nih.gov/pubmed/25113800
http://dx.doi.org/10.1186/s12967-014-0215-0

Ejemplares similares